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The binding of two organohalogen substances, pentabromo-
phenol (PBP) and 2,4,6-tribromophenol (TBP), to human
transthyretin (TTR), a thyroid hormone transport protein, has
been studied by in vitro competitive binding assays and by
X-ray crystallography. Both compounds bind to TTR with
high af®nity, in competition with the natural ligand thyroxine
(T4). The crystal structures of the TTR±PBP and TTR±TBP
complexes show some unusual binding patterns for the
ligands. They bind exclusively in the `reversed' mode, with
their hydroxyl group pointing towards the mouth of the
binding channel and in planes approximately perpendicular to
that adopted by the T4 phenolic ring in a TTR±T4 complex, a
feature not observed before. The hydroxyl group in the
ligands, which was previously thought to be a key ingredient
for a strong binding to TTR, does not seem to play an
important role in the binding of these compounds to TTR. In
the TTR±PBP complex, it is primarily the halogens which
interact with the TTR molecule and therefore must account
for the strong af®nity of binding. The interactions with the
halogens are smaller in number in TTR±TBP and there is a
decrease in af®nity, even though the interaction with the
hydroxyl group is stronger than that in the TTR±PBP
complex.
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1. Introduction
Organohalogen substances (OHSs) are present as residues in
the environment for several reasons. They are generated
either as by-products formed in the commercial production of
industrial chemicals or by further reactions of the chemicals
during combustion processes. They can also be the result of
metabolic processes if these chemicals are absorbed by living
organisms. These compounds have a wide range of application
as pesticides, adhesives, ¯ame retardants, dielectric ¯uid for
transformers and capacitors, lubricants, sealants and even in
carbonless copy paper (Safe, 1994). In recent years, it has been
shown that exposure to these compounds can adversely affect
the thyroid hormone system in animals and humans (Brouwer
et al., 1998). One level of interference of OHSs with the
thyroid hormone system is through interactions with trans-
thyretin (TTR), one of the proteins responsible for the
transport of the thyroid hormones in blood plasma. A rela-
tively constant level of free thyroid hormones in the blood is
maintained by equilibrium reactions with the transport
proteins to which more than 99% of the hormones are bound
(Robbins, 1991). Any variation in the hormone binding with
the transport proteins can therefore affect the level of free
hormones in the blood. Severe reductions in thyroxine levels
in the plasma of laboratory animals, wildlife and humans have
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been reported following exposures to OHSs such as poly-
chlorinated biphenyls (PCBs) and polybrominated biphenyls
(PBBs) (Brouwer et al., 1998; Pluim et al., 1993; Van den Berg
et al., 1988). In vitro binding studies with several groups of
OHSs have shown that these compounds are able to bind to
TTR with a potency comparable to or higher than that of the
natural ligand thyroxine (T4) (Lans et al., 1993, 1994). In
contrast, these compounds do not bind with thyroxine-binding
globulin (TBG), the major carrier of thyroid hormones in
mammals (Lans et al., 1993; Rickenbacher et al., 1986; Van den
Berg, 1990; Van Raaij et al., 1991). The depletion of the
thyroxine levels in blood of the laboratory animals following
exposure to OHSs may therefore be explained by competitive
binding of these organohalogens to TTR, inhibiting the
interaction of the protein with its natural ligand T4 or other
iodothyronines.
In vitro binding studies have shown that the OHSs bind to
TTR with a wide-ranging af®nity for the protein and attempts
have been made to ®nd a correlation between the structure
and af®nity of the ligands. The degree of halogen substitution
was found to be important, as the higher halogenated phenols
(Van den Berg, 1990) and bisphenols (Meerts et al., 2000)
showed a higher af®nity for the T4 binding site compared with
the lower halogenated compounds. The presence of a hydroxyl
group at the para or meta positions of the phenyl rings of
polychlorinated biphenyls, with at least one chlorine substi-
tution at an adjacent position, was thought to be an essential
prerequisite for TTR binding (Lans et al., 1993). However, it
has also been shown that some parent compounds without the
hydroxyl group are capable of binding TTR (Chauhan et al.,
1998; Meerts, unpublished results), though the binding is
weak.
In order to obtain a better understanding about the nature
of the interaction of OHSs with TTR at the molecular level,
we studied two brominated compounds (Fig. 1), pentabro-
mophenol (PBP) and 2,4,6-tribromophenol (TBP). Here, we
present the results of in vitro TTR±T4 competitive binding
experiments with these compounds using radiolabelled thy-
roxine 125I-T4 and the structural details of ligand binding as
determined by X-ray crystallography at 100 K.
2. Experimental procedures
2.1. Binding studies
2.1.1. In vitro T4 competition binding assays on TTR. A
competition binding assay using the gel-®ltration procedure
(Somack et al., 1982) was used with minor modi®cations to
measure the ability of the PBP (Aldrich Chemical Company,
Bornem, Belgium) and TBP (Fluka Chemie, Buchs, Switzer-
land) to displace radiolabelled l-30,50-(125I) thyroxine from the
high-af®nity TTR-binding site. The assay buffer used was
0.1 M Tris±HCl pH 8.0 containing 0.1 M NaCl and 1 mM
EDTA. The incubation mixture contained 30 nM human TTR
(98% pure, Sigma, USA), a mixture (70 000 counts minÿ1,
55 nM) of 125I-T4 (speci®c activity 46 mCi mg
ÿ1, Amersham,
UK) and unlabelled T4 (Sigma, USA) and graded concen-
trations of competitor (unlabeled T4 or PBP/TBP dissolved in
dimethylsulfoxide, 99.9% pure, Janssen Chimica, Geel,
Belgium) in assay buffer. The ®nal concentration of the
unlabelled compounds was in the range 10ÿ9 to 10ÿ7 M. The
®nal volume of the incubation mixture was 0.2 ml. The total
125I radioactivity added to each of the incubation mixtures was
checked by gamma-counting (Multi Prias, Packard Instrument
Co., USA). The incubation mixtures were allowed to reach
binding equilibrium overnight at 277 K. Biogel P-6DG (Bio-
Rad Laboratories, Richmond, CA, USA) columns were
prepared in a 1 ml disposable syringe, equilibrated with the
assay incubation buffer and 300 ml 10%(w/v) sucrose/Tris±HCl
buffer. Protein-bound 125I-T4 and free
125I-T4 were spin-forced
separated on the columns by centrifugation at 1000 rev minÿ1
(100g) in a precooled centrifuge (Difuge, Hereaus). The
columns were spin-forced eluted with an additional volume of
200 ml Tris±HCl buffer. Radioactivity in the eluate fraction
was determined and compared with control incubations.
2.1.2. Analysis of binding data. Competition binding curves
were made by plotting relative 125I-T4 protein binding
(percentage of control) against added log competitor
concentration. Calculation of binding parameters was
performed with the LIGAND-PC program (Munson &
Rodbard, 1980). Each assay contained duplicate measure-
ments and assays were repeated three times. The binding
potency of PBP/TBP relative to that of thyroxine was calcu-
lated by the ratio of unlabelled T4 concentration at 50% of
total binding IC50(T4) to ligand concentration at 50% of total
binding (IC50 PBP/TBP). Competition binding assays with
unlabelled T4 were used as reference assays.
2.2. X-ray crystallographic studies
2.2.1. Co-crystallization of the TTR±bromophenol
complexes. Solutions of PBP (6.1 mM) and TBP (14.6 mM)
were prepared by dissolving the compounds in DMSO (Sigma,
Figure 1
Schematic diagram of pentabromophenol, 2,4,6-tribromophenol and
thyroxine.
UK). To form the complexes, 25 ml of TTR (Sigma, UK)
solution (0.37 mM in 100 mM Tris buffer containing 100 mM
NaCl and 1 mM EDTA at pH 8) was mixed with 2 ml of each of
the bromophenol solutions in microbridges which were then
sealed with cover slips and allowed to incubate for 1 d at
277 K. The ®nal molar concentrations were in the ratio 34:45
and 34:110 for TTR:PBP and TTR:TBP, respectively. Two sets
of crystallizations were set up at 295 and 277 K, respectively, in
2 ml hanging drops containing protein±ligand complex and the
precipitants in 1:1(v/v) ratio and were allowed to equilibrate
over a reservoir of 50±55% ammonium sulfate in 100 mM
sodium citrate buffer pH 7. Crystals appeared in the drops at
295 K after nearly two months. Native TTR crystals were
grown under similar conditions.
2.2.2. Data collection. Cryogenic techniques (Garman &
Schneider, 1997) were used for collecting the diffraction data.
A complete set of data was collected from a single frozen
crystal in each case, using a 30 cm MAR Research image-plate
detector mounted on a Rigaku RU-200 rotating-anode source
of Cu KX-radiation. Prior to freezing, 10 ml drops of glycerol
solution in the crystallization buffer were gradually added to
the drops containing the crystals so that the concentration of
glycerol in the drop increased approximately to 40% to
prevent ice formation in the crystal at sub-zero temperatures.
The crystals were then transferred by means of tiny woollen
loops and ¯ash-frozen in a stream of cold gaseous nitrogen at
100 K and were kept at that temperature during the entire
data collection. The crystal-to-detector distance was set at
120 mm for the complex crystals, the resolution at the edge of
the detector being 1.8 AÊ ; for the native crystal, the detector
distance was 116 mm (1.75 AÊ at the edge). The data were
processed using the programs DENZO and SCALEPACK
(Otwinowski & Minor, 1997). For the native crystal, the
re¯ections beyond 1.9 AÊ were not used because of poor I/(I)
and Rmerge values. Structure factors were derived from inten-
sities using the program TRUNCATE from the CCP4 package
(Collaborative Computational Project, Number 4, 1994). All
three types of crystals were isomorphous to native TTR
crystals at room temperature (Blake et al., 1978; Hamilton et
al., 1992) and belonged to the orthorhombic space group
P21212.
2.2.3. Refinement and validation of the final structure.
Re®nement of the structures was carried out by alternate
cycles of the X-PLOR package version 3.851 (BruÈ nger, 1992)
and manual ®tting of the model into the electron-density maps
using O (Jones & Kjeldgaard, 1997). The structure of native
transthyretin, solved at room temperature to 1.7 AÊ resolution
(Hamilton et al., 1992), was used as a starting model; the
N-terminal residues (1±9) and C-terminal residues (124±127)
were removed as these were not well ordered in the native
structure. Residues with double conformations were initially
replaced by alanines. 5% of the re¯ections were set aside for
use as a test set to monitor the re®nement process by calcu-
lating Rfree (BruÈ nger, 1992). Initially, the two monomers in the
asymmetric unit were re®ned as two rigid objects. Fourier and
difference Fourier maps calculated at this stage clearly showed
the positions of the ligands in the binding channel, the peaks
corresponding to the halogen atoms being the highest in the
maps.
The coordinates of the pentabromophenol (PBP) molecule
were obtained from the Cambridge Structural Database using
QUEST (Allen & Kennard, 1993). The molecule was ®tted
into the electron-density map and included in the model for
structure-factor calculations in the subsequent re®nements.
PBP was found to bind at two ligand-binding sites symme-
trically on the crystallographic dyad along z, which runs along
the binding channel. At each site, one half of the molecule was
included in the atomic coordinate set with occupancy 1, while
the other half was generated by the twofold rotation about z.
At one of these binding sites there was evidence of an addi-
tional low-occupancy binding for the PBP molecule. Only the
Br atoms of the molecule could be detected on the 2Fo ÿ Fc
map, where no density was to be seen for the C atoms on the
ring structure of the molecule. However, the observed ®ve
peaks ®tted exactly with the Br-atom positions in PBP. This
de®ned the position of the ligand in this mode without any
ambiguity. The peak heights for these Br atoms were
comparable to those of O atoms in ordered water molecules
and they were treated as water molecules during the re®ne-
ment. The occupancy of the ligand in the secondary mode
could be approximately estimated to be less than 25% of that
in the principal mode by comparing the numbers of scattering
electrons in Br and O (35:8).
For 2,4,6-tribromophenol (TBP), a modi®ed model based
on PBP was used because the structure was not available in
the database. In the binding of the TBP, unlike PBP, the
molecular twofold axis of the ligand was not coincident with
the crystallographic twofold axis parallel to the z axis; the
ligands occupied two symmetry-related sites each with 50%
occupancy at each binding site.
Each model was subjected to cycles of positional re®ne-
ment, simulated annealing and restrained isotropic atomic
temperature-factor re®nements. After each cycle of B-factor
re®nement, the models were examined on the graphics and
re®tted to the density. Water molecules were added to the
atomic model using WATERPICK (in X-PLOR); they were
placed at the positions of high positive (>3.5) peaks in the
difference Fourier maps provided that they were (i) also
present in the 2Fo ÿ Fc electron-density map and (ii) in a
suitable hydrogen-bonding environment. Water molecules
whose temperature factors re®ned to values greater than
60 AÊ 2 were discarded from the model. Bulk-solvent correc-
tions were applied and the lower resolution limit of the data
included in the re®nement was extended to 20 AÊ at a later
stage of re®nement. The ®rst nine N-terminal residues and the
last three or four C-terminal residues of TTR were not visible
in any of the structures. The re®ned structures were analysed
for geometric quality using PROCHECK (Laskowski et al.,
1993).1 Atomic contacts between the protein, the ligands and
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the water molecules were calculated using CONTACT
(Collaborative Computational Project, Number 4, 1994).
3. Results
3.1. Binding studies
Fig. 2 shows the competitive binding of PBP and TBP to
transthyretin using 125I-T4 as the displaceable radioligand.
Binding-af®nity constants (Ka) were determined by non-linear
curve ®tting of T4 displacement curves. The best-®t parameters
are shown in Table 1. PBP is about seven times more potent
than unlabelled T4 in this assay system, while TBP has an
af®nity comparable to T4.
3.2. X-ray crystallographic studies
A summary of the data-collection and re®nement statistics
for the native and the bromophenol-bound TTR structures is
given in Table 2. The structures of the native TTR and TTR±
bromophenol complex molecules at 100 K are very similar to
that of native TTR at room temperature (Blake et al., 1978;
Hamilton et al., 1992). The backbone structure of the protein
remains unaltered by the introduction of the ligands into its
binding channel, as has been the case for other ligand-bound
TTR molecules (Blake & Oatley, 1977; Ciszak et al., 1992; De
la Paz et al., 1992; Lans et al., 1993; Peterson et al., 1998;
Wojtczak et al., 1992, 1993, 1996).
Transthyretin is a tetrameric molecule formed by four
monomers of an identical sequence of 127 residues and
arranged in a 222 symmetry, three twofold axes intersecting at
the centre of the molecule (Fig. 3a). One of these molecular
twofold axes is coincident with the crystallographic twofold
(z) axis, while the other two are coincident with the 21
(x and y) axes. Each monomer of TTR is a wedge-shaped -
barrel formed by two four-stranded sheets hgad and febc. Two
such monomers (A and B) join edge-to-edge to form a dimer,
stabilized by extensive antiparallel hydrogen bonding between
the -strands h and f at the edge of the monomers (Fig. 3b).
The dimer AB thus formed is a pair of eight-stranded -sheets
with a pronounced concave shape because of the right-handed
twist of the strands. A rotation of the dimer about the crys-
tallographic twofold axis along z produces the tetramer
ABCD where the dimer±dimer interaction involves the edges
of the concave sheets. This creates a 50 AÊ long central channel
running through the entire length of the TTR molecule along
the z axis, which has been identi®ed as the hormone/ligand-
binding site (Blake & Oatley, 1977).
There are two binding sites in this channel (AC between the
monomers A and C, and BD between the monomers B and
D), each of which has an intrinsic twofold symmetry as these
are located on the z axis. When an asymmetric molecule such
as a thyroid hormone binds to the protein, it binds in two
different orientations symmetrically disposed about the
twofold axis, each with a statistical probability of half occu-
pancy (Fig. 4a). The sites AC and BD are structurally
equivalent, being related to each other by a non-crystallo-
graphic symmetry axis. The extended binding site has a
Table 1
Relative binding af®nities of pentabromophenol and 2,4,6-tribromo-
phenol for the T4 binding site on transthyretin.
Results shown are means  standard deviation of at least triplicate
measurements.
Structure IC50 (nM)² Relative potency³ Ka (M
ÿ1) (mean  s.d.)§
Thyroxine 80.72  1.21 1 3.50  0.30  107
PBP 11.45  1.78 7.14  1.11 2.56  0.40  108
TBP 67.25  2.74 1.20  0.05 4.30  0.18  107
² IC50 values were determined from the competition curves and represent the
concentration at 50% of total (125I)-T4 binding to TTR. ³ Relative potencies are
given as the ratio of IC50(T4)/IC50 (competitor). § Binding-af®nity constants are
determined by the LIGAND-PC program (Munson & Rodbard, 1980).
Table 2
Data-collection and re®nement statistics.
Numbers in parentheses denote values in the highest resolution shell.
Native PBP² TBP³
Data collection
Space group P21212 P21212 P21212
Unit-cell parameters (AÊ )
a 42.7 43.0 42.8
b 85.4 85.4 84.9
c 64.2 64.3 64.4
Maximum resolution (AÊ ) 1.75 1.8 1.8
Highest resolution shell (AÊ )
of the data used
1.99±1.9 1.88±1.8 1.88±1.8
Total No. of observations 215400 119292 249678
Unique re¯ections 16505 (2102) 22174 (2762) 20818 (2543)
Completeness (%) 85.7 (88.7) 97.6 (99.4) 92.7 (92.8)
Mean I/(I) 22.1 (3.6) 21.2 (3.4) 29.4 (3.7)
Data with I > 3(I)§ (%) 85.9 (57.6) 83.4 (50.0) 85.2 (54.3)
Redundancy} 3.2 (3.0) 2.6 (2.5) 3.7 (3.6)
Rmerge²² (%) 3.9 (22.8) 5.8 (27.9) 4.8 (34.5)³³
Wilson B factor 28.3 21.7 24.5
Re®nement
Resolution range (AÊ ) 20±1.9 20±1.8 20±1.8
No. of re¯ections 16447 22132 20764
R§§ (%) 19.3 19.3 21.4
Rfree}} (%) 25.2 23.5 26.2
No of water molecules 80 151 147
Average B (AÊ 2)
Protein 33.3 23.4 19.4
Water 43.2 34.3 33.8
Ligand 35.3 45.8
R.m.s.d. bond lengths (AÊ ) 0.009 0.007 0.008
R.m.s.d. bond angles () 1.5 1.4 1.4
R.m.s.d. dihedral angles () 27.5 26.8 26.4
R.m.s.d. impropers () 1.4 1.3 1.4
Ramachandran plot quality
% in core allowed regions 88.6 89.1 89.6
% in additional allowed
regions
11.4 10.9 10.4
² PBP, pentabromophenol. ³ TBP, 2,4,6-tribromophenol. § No  cutoff was applied.
} Average number of measurements for each re¯ection which contributed to the
calculation of Rmerge. ²² Rmerge =
P
hkl |hIhkli ÿ Ihkl|/
P
hklhIhkli, where hIhkli represents
the average intensity of symmetry-equivalent re¯ections. ³³ Two data sets were
collected from one TBP complex crystal; the Rmerge for the highest resolution shell (1.88±
1.8 AÊ ) of the ®rst data set was 24.5. A second data set, collected with a shorter exposure
time per image to avoid overload of the strong re¯ections, was merged with the ®rst one.
Strictly speaking, the effective resolution of this merged data set of the TBP complex is
1.9 AÊ . However, the re®nement was carried out including all data to 1.8 AÊ , because the
signi®cant part of the data was certainly reliable to 1.8 AÊ . §§ R =
P
hkl
(|Fo| ÿ |Fc|)/P
(Fo), for a working set comprising of 95% of the data. }} Rfree =
P
hkl
(|Fo| ÿ |Fc|)/P
(Fo), for a test set comprising of 5% of the data selected randomly.
hydrophilic region closest to the centre which comprises pairs
of Ser112, Ser115, Ser117 and Thr119 from two monomers,
followed by a hydrophobic region with pairs of Leu17, Ala108,
Ala109, Leu110 and Val121. There are three pairs of
symmetry-equivalent pockets in between the grooves of the
-sheets forming the binding cavity, in which the I atoms of T4
bind. While the two I atoms (3,5) on the tyrosine ring of T4
occupy the symmetrically related outer pockets at about 13 AÊ
from the centre, the phenolic I atoms bind in two of the four
inner pockets, which are not related by symmetry. In the
native TTR structure the innermost `distal' pockets at a
distance of 6 AÊ from the centre are occupied by a pair of water
molecules, which are displaced by one of the iodines (30 or 50)
on the phenolic ring of T4. The other phenolic I atom binds in
the `proximal' pockets, 9 AÊ from the centre.
3.2.1. TTR±pentabromophenol (PBP) complex. The differ-
ence Fourier and the electron-density map of the TTR±PBP
complex showed the positions of PBP bound in the binding
channel at two binding sites AC and BD between two sets of
symmetry-related monomers of TTR (Fig. 4b), with no indi-
cation of binding anywhere else. The symmetrical molecules of
PBP are bound, with their Br4 atoms at a distance ’ 7 AÊ from
the centre of the TTR tetramer and the (Br4ÐOH) axis of the
molecule coincident with the z axis. The peaks of Br atoms
were the highest in the map (6) and unambiguously showed
that PBP binds exclusively in the so-called `reversed' mode as
the OH group of the ligand does not point to the centre of the
TTR tetramer but towards the mouth of the binding cavity.
The Br atoms Br4 are closest to the centre of TTR and
interact with a pair of symmetry-related and well ordered
water molecules at each binding site: W9/V9 at the AC end and
W5/V5 at the BD end at a distance of 3.5±3.6 AÊ (Figs. 5a and
5b). (Water molecules are labelled W in one monomer and V
in the symmetry-related monomer.) These water molecules
are hydrogen bonded with pairs of Ser117 and Thr119 from
neighbouring monomers and are also present in the native
TTR structure, making similar interactions. The Br atoms
adjacent to Br4 (Br3 and Br5) have extensive interactions with
their nearest Thr119 (C, C2 and O1), as well as with Ala108
and Leu17. Most of the interactions here are hydrophobic in
nature, except the one with Thr119 O1 (3.7 AÊ ). The
remaining Br atoms, Br2 and Br6, are adjacent to the hydroxyl
group and are at a distance of about 12 AÊ from the centre of
the TTR tetramer. These are in the hydrophobic environment
of Val121, Leu17 and Lys15 from the two monomers on the
two sides of the binding channel. However, they also interact
with water molecules W217 (and V217) at a distance 3.5 AÊ at
the AC end and with W229 (and V229) at a distance of 3.6 AÊ at
the BD end of the molecule.
At the binding site between the monomers B and D, the
ligand shows clear evidence of a second mode of binding
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Figure 2
Competitive binding of pentabromophenol (PBP) and 2,4,6-tribromo-
phenol (TBP) to transthyretin. Data are mean values of triplicate
incubations. If no error bar is visible, it is smaller than the marker.
Figure 3
Ribbon diagram of transthyretin showing (a) the tetramer ABCD, with
monomer A±D in colour ramping from blue to red. 50 AÊ long thyroxine-
binding channel is shown along the z axis. (b) The monomers A and B
joined side by side to form the dimer AB. The eight strands in each
monomer are labelled a±h. The ®gures were created using the programs
BOBSCRIPT (Esnouf, 1997) and rendered with Raster3D (Merritt &
Murphy, 1994).
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(termed PBP2) of lower occupancy in addition to the one just
described (Fig. 4b). In this mode, the bound PBP molecule is
still symmetrical about the channel axis with the axial atoms
occupying identical positions, but the phenolic ring of the
molecule is nearly at right angles to that in the principal mode.
The interaction of the Br atoms are again mostly hydrophobic,
with the residues Lys15, Leu17, Ala108, Ala109 and Leu110
(Fig. 5b), but there are also hydrophilic interactions with some
main-chain and side-chain atoms. The electron density around
the pair of Leu17 residues at this binding site is broad and
indicates a disordered conformation of the residue to
accommodate PBP Br atoms in two different modes. Some of
the interatomic distances between Lys15 side-chain atoms and
Br2 (and Br6) in this mode are much smaller (2.6±3.4 AÊ ) than
the acceptable van der Waals separation (3.3±3.5 AÊ ). This
probably suggests that in this mode the Lys15 residues assume
a different conformation which is not detectable on the
electron-density map as the occupancy is low. The interactions
of the axial atoms of PBP remain unaffected as they have
identical positions as in the principal mode.
The interaction with the OH group of the ligand at the
mouth of the channel is different at the two ends of the
molecule. At the AC end, the N of each Lys15 is locked in a
triangular hydrogen-bond interaction with water molecules
W217 (V217) and W64 (V64). It also interacts with the O"1 of
the corresponding Glu54 but not with the OH group of the
ligand. At the BD end, Lys15 is strongly hydrogen bonded to
the OH group of the ligand and the water molecules W/V229,
but has no interaction with Glu54 residues. The contacts
between PBP and TTR in the major binding mode PBP1 and
the secondary mode PBP2 are listed in Tables 3(a) and 3(b).
The residues at the binding site of the TTR±PBP complex
have very similar conformations to those of the native TTR at
100 K and at room temperature, except for Leu17 and Thr119.
Both these residues undergo large rotations of about 120 to
make space for Br3 and Br5 and to avoid steric hindrance.
3.2.2. TTR±2,4,6-tribromophenol (TBP) complex. The
2,4,6-tribromophenol molecule differs from pentabromo-
phenol in the absence of Br atoms at the positions 3 and 5
(Fig. 1). This leads to a signi®cant reduction in its binding
Figure 4
Diagrams showing the ligands in the TTR binding sites AB and CD; the halogens are in deep purple, O atoms in red, N atoms in blue and the C atoms are
in grey. (a) In the TTR±T4 complex, the asymmetric molecule of T4 binds in two symmetry-related positions with half occupancy at each binding site. The
I atoms on the phenolic rings bind in the inner pockets and those on the tyrosine ring bind in the outer pockets. (b) and (c), 2Fo ÿ Fc maps around the
ligands PBP and TBP, respectively, contoured at 1. The ®gures were created using the programs BOBSCRIPT (Esnouf, 1997) and rendered with
Raster3D (Merritt & Murphy, 1994).
af®nity with TTR as shown by the binding study. TBP binds
exclusively in the `reversed' mode at two sites in the TTR
binding cavity (Fig. 4c), about 8 AÊ away from the centre of
molecule and in an orientation similar to PBP. Unlike PBP, the
molecular axis of TBP is slightly offset from the twofold z axis
and at each binding site it occupies two symmetry-related
positions with 50% occupancy. The binding of TBP molecules
at the two sites at the AC and BD end of the molecule are
similar but not identical. There is no secondary binding
observed at either of these sites.
The interactions of TBP with the neighbouring residues are
mostly similar to those in PBP, except for Leu17. The absence
of Br atoms in positions 3 and 5 allows Leu17 residues to
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Figure 5
Interaction of the ligands with TTR residues and water molecules (a) at the binding site AC of the the TTR±PBP complex, where the ligand binds in
single mode PBP1, (b) at the binding site BD of the TTR±PBP complex, where the ligand binds in double mode PBP1 and PBP2 with fractional
occupancies, and (c) at the binding site AC of the TTR±TBP complex, where TBP binds in two symmetry-related positions with half occupancy.
Hydrogen bonds are shown as thin lines. The ®gures were created using the program XOBJECTS (M. E. M. Noble, unpublished program).
assume an orientation similar to that in the native TTR
structure. The water molecules through which Br atoms Br2
and Br6 of PBP interact with the pair of Lys15 residues on the
neighbouring monomers are absent in the TTR±TBP complex.
Instead, the lysines interact directly with Br2 and Br6 (3.6 and
4.1 AÊ ; Fig. 5c). The OH group of the molecule is almost on the
z axis, and makes two symmetrical hydrogen bonds (3 AÊ ) with
the N atoms of the Lys15 residues at both end of the binding
channel, in addition to a number of non-polar interactions
with the same residue. The interaction of Br4 atoms with the
conserved water molecules near the TTR centre (W46/V46 at
the AC end and W58/V58 at the BD end) is similar, but is weak
compared with that in PBP as the molecule does not bind as
deep as PBP into the binding cavity. At the site BD, Br4 atoms
have an additional interaction with an water molecule W336
located on the z axis, which is absent at the AC site as well as
in the TTR±PBP complex. The separation between the two
symmetry-related Br4 atoms at the site BD is wider (2.9 AÊ )
than at the site AC (1.7 AÊ ). The contact distances between
TBP and surrounding residues of TTR are listed in Table 3(c).
4. Discussion
4.1. Unusual binding of PBP and TBP with TTR
Comparison of the TTR±PBP structure with that of TTR±
T4 (Blake & Oatley, 1977; Wojtczak et al., 1996) shows that in
the major binding mode PBP1 the ligand binds with its plane
approximately at right angles to the phenolic planes of T4
(Fig. 6a). While the Br atoms Br2 and Br6 occupy positions
close to the outer I-atom positions I3 and I5 on the tyrosine
ring of T4, the other three Br atoms of the ligand are not in any
conventional iodine pockets. For the secondary mode PBP2,
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however, the ligand is in similar orientation as the phenolic
ring in T4: Br3 and Br5 occupy the inner proximal pockets (I3
0
and I50) of T4 (Fig. 6b). In both PBP1 and PBP2, Br4 has a
position close to and in the middle of the two positions where
the OH groups of T4 bind. Thus, in each mode, only two of the
®ve Br atoms of the ligand can occupy the iodine pockets of
T4. The crucial difference between the two molecules that
forces PBP to assume such an unusual binding position lies in
the fact that the Br atoms in PBP are coplanar, while the I
atoms in T4 attached to the phenolic ring (3
0,50) and the
tyrosine ring (3,5), have a pseudo-tetrahedral arrangement
which matches the positions of the halogen pockets in the
TTR-binding cavity. Any two of the PBP Br atoms can thus
occupy the positions of T4 I atoms either on the phenolic ring
or those on the tyrosine ring. As the twofold symmetry of the
site coincides with that of the PBP molecule, the ligand rotates
about its molecular axis and chooses one of the two options.
The other three Br atoms are restricted to positions in the
same plane, even though these are not the conventional
halogen-binding pockets.
Interestingly, PBP in its principal binding mode PBP1
prefers the position where Br2 and Br6 occupy the iodine
pockets of the T4 tyrosine ring (the so-called outer pockets)
and not the positions where its Br3 and Br5 atoms ®ll in the
inner proximal pockets, which remains a possible binding
option as is shown in the low-occupancy secondary mode.
Binding of halogens at these outer pockets depends on the
interactions between the bromines and the neighbouring
residues which play an important deciding role in the way the
ligands bind. In the principal mode of PBP1, each of the non-
axial atoms in the ligand makes a number of contacts, mainly
hydrophobic, with both the monomers. This would increase
the stability of the dimers AC and BD. In the secondary
binding mode, observed only at one site, such interactions are
limited to just one monomer, i.e. one half of the molecule is
entirely in the environment of and interacting with the
monomer B, while the other half is interacting with D. The
atoms on the axis of the ligand occupy identical positions in
both modes and interact with both monomers.
The binding pattern in the TTR±TBP complex reinforces
the observation that the outer T4 pockets where Br2 and Br6
bind provide a more suitable environment for halogen
binding. The positions of these Br atoms in two symmetry-
related orientations of the ligand are not coincident as is the
case in TTR±PBP but are separated by a small distance as are
Table 3
Interatomic distances.
Hydrogen bonds are in bold.
(a) Interatomic distances between TTR and PBP molecule in the primary
mode.
PBP primary binding site at
AC BD
Ligand atom Protein atom Distance (AÊ ) Protein atom Distance (AÊ )
Br2 WatV217 O 3.5 WatV229 O 3.6
LysD15 Nz 3.6
LeuD17 C1 3.1
Br3 ThrA119 C 3.5 ThrB119 C 3.6
LeuD17 C1 3.2
Br4 WatW9 O 3.5 WatW5 O 3.6
WatV9 O 3.5 WatV5 O 3.6
Br5 ThrC119 C 3.5 ThrD119 C 3.6
LeuB17 C1 3.2
Br6 WatW217 O 3.5 WatW229 O 3.6
LysB15 N 3.6
LeuB17 C1 3.1
O1 LysD15 N 2.9
LysB15 N 2.9
C2 LeuD17 C1 3.3
C3 LeuD17 C1 3.3
C5 LeuB17 C1 3.3
C6 LeuB17 C1 3.3
(b) Interatomic distances between TTR and PBP molecule in the secondary
binding mode, at the site BD².
PBP secondary binding site at BD
Ligand atom Protein atom Distance (AÊ )
Br2 LysD15 C 3.4
LysD15 C 2.6
LysD15 C" 3.0
LysD15 C 2.9
LeuD17 C1 3.1
Br3 AlaD108 C 3.4
AlaD109 N 3.6
AlaD109 C 3.6
AlaD109 O 3.5
LeuD17 C1 3.2
Br5 AlaB109 O 3.6
LeuB17 C1 3.2
AlaB108 C 3.4
AlaB109 N 3.6
AlaB109 C 3.6
Br6 LysB15 C" 3.0
LeuB17 C1 3.1
LysB15 C 2.6
LysB15 C 3.4
LysB15 C 2.9
C2 LeuD17 C1 3.3
C3 LeuD17 C1 3.3
C5 LeuB17 C1 3.3
C6 LeuB17 C1 3.3
Table 3 (continued)
(c) Interatomic distances between TBP and TTR at the two binding sites.
TBP binding at the site
AC BD
Ligand atom Protein atom Distances (AÊ ) Protein atom Distances (AÊ )
Br2 LeuC17 C1 3.6
LysB15 N 3.4
Br4 LeuB17 C1 3.4
WatW336 OH 3.3
Br6 LysA15 N 3.6 LysD15 N 3.6
O1 LysA15 N 3.0 LysB15 N 2.8
LysC15 N 3.1 LysD15 N 3.0
C3 LeuB17 C1 2.9
C5 LeuA17 C1 3.2
² The distances between the protein and the ligand atoms Br4 and O1 are identical to
those in primary mode.
the I atoms in the TTR±T4 complex. The separation is 0.5 AÊ
(0.8 AÊ for TTR±T4) at the AC end compared with 1.4 AÊ (1.6 AÊ
for T4) at the BD end, i.e. the pockets are extended over a
smaller area at the AC end. The exact position of the pockets
has also been found to be quite ¯exible in other complex
structures and is determined by the interaction of the halogens
with the neighbouring residues and the steric hindrance the
ligand molecule experiences at the narrow central part of the
binding channel.
The interactions of Br4, the Br atoms which are in a polar
environment at the centre of the TTR molecule, are quite
exceptional. In other TTR complex structures, it is usually the
OH group of the phenolic ring in the forward mode (or the
amino-acid side chain in case of a reversed mode of entry)
which interacts with the polar residues and the bound water
molecules at the centre. A search through the Isostar
(Lommerse et al., 1996) database shows that polar reactions of
aromatic Br atoms are relatively uncommon, although it has
been observed (Bruno et al., 1997) that carbon-bonded halo-
gens (with the exception of ¯uorine) can form contacts with
electronegative atoms such as oxygen, nitrogen and sulfur and
that the contact distance can be smaller than the sum of the
van der Waals radii in the direction of the bond connecting the
C atom and the halogen. This has been explained in terms of
an anisotropic electron distribution of the halogen atoms
which results in a decreased repulsive wall and an increase in
the electrostatic attraction in the direction of the carbon±
halogen bonds. In these two TTR complexes, most of the
contact distances are within the range 3.5±3.8 AÊ , which
exceeds the sum of van der Waals radii of oxygen and bromine
(3.35 AÊ ). The 3.3 AÊ contact distance between two symmetrical
Br4 atoms and the axial water molecule W336 at the BD end in
the TBP complex is the only interaction which is shorter than
the sum of van der Waals radii and it makes an angle of 138
with the C4ÐBr4 bond.
The water molecules near the centre of the binding channel
of the bromophenol complexes form part of an extensive
network of hydrogen bonds with residues Ser112, Ser115,
Ser117 and Thr119, which also exists in the native TTR
tetramer. The halogens, through their interactions with these
water molecules, contribute to the links that hold the subunits
together. This probably explains the considerably higher af®-
nity of PBP in comparison to TBP. A similar increase in the
binding af®nity has been observed for TTR±chlorophenol
complexes from monochlorophenol to pentachlorophenol, in
proportion to the number of chlorine substituents (Van den
Berg, 1990).
A signi®cant difference between the dimers has been
observed in all the three structures, namely in the loop
connecting the strands f and g, residues 97±104. This loop is
ordered and has good density for the monomers A and C,
whereas in B and D this is disordered. The g strand lies in
between the strands a and h, i.e. between the N- and
C-termini. The ®rst nine and the last 3/4 residues of TTR have
not been observed in any X-ray structure [with one exception
of the 1.7 AÊ structure of wild type and the amyloidogenic
variant Val30-Met30 TTR (Hamilton et al., 1992), where the
N- and C-termini were modelled and re®ned to ®t the
disconnected densities observed in the vicinity of the termini],
presumably because of the ¯exible nature of the chain in these
two regions. There has been speculation (Wojtczak et al., 1993)
about the role that these mobile termini play in ligand binding
because of their proximity to the entrance of the binding
channel.
The dissimilar binding of the ligand molecules and the
difference in the various interactions at the two binding sites
observed in these two complex structures provides the ®rst
X-ray evidence that the AC and BD dimers are not identical in
their interactions. In all TTR±ligand complex structures prior
to this current study, the binding of ligands at the two sites
were found to be similar. Chemical evidence, however, showed
that for T4 and several other hormone analogues, these
binding sites have different af®nity. For T4, only one molecule
binds with high af®nity ’ 108 Mÿ1 (Raz & Goodman, 1969;
Nilsson & Peterson, 1971; Pages et al., 1973), while the second
site has an af®nity 100-fold less than the ®rst site (Cheng et al.,
1977). The exact reason for such disparity is yet to be under-
stood.
4.2. Reversed binding and comparisons with other ligand
structures
The other interesting feature observed in these two complex
structures, that the ligands bind exclusively in a reversed mode
with their hydroxyl groups pointing towards the mouth of the
binding cavity, is a rare occurence. The only other example of
such exclusive reversed binding has been observed in the
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Figure 6
Superposed view of thyroxine on the ligand PBP at the TTR±PBP
binding site. (a) In its principal binding mode PBP1, the Br atoms Br2 and
Br6 occupy the outer pockets of thyroxine while (b) in the secondary
binding mode PBP2, Br3 and Br5 are in the inner pockets of the hormone.
I atoms are shown in gold and Br atoms are in rust red. The ®gures were
created using the program XOBJECTS (M. E. M. Noble, unpublished
program).
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TTR±¯ufenamic acid complex (Peterson et al., 1998), where
the CF3 substituents occupy the innermost pockets and the
carboxylate group on the outer phenyl ring is located near the
entrance of the binding cavity, interacting with Lys15s.
The possibility of partial reversed binding in addition to the
more common `forward binding' has been discussed (De la
Paz et al., 1992) with reference to the TTR complexes with
30,50-diiodo-l-thyronine (30,50-T2), 3,30-diiodo-l-thyronine
(3,30-T2) and 3,30,50-triiodo-l-thyronine (reverse T3/RT3). In
the light of these observations, the results of TTR±T4 and
TTR±T3 could also be reinterpreted in terms of a mixture of a
forward and reversed binding. It was concluded that 30,50±T2
and RT3 bind in a combination of reversed and forward mode
in an estimated ratio of 60:40. The ligand 3,30-T2 binds in the
reverse mode as well as two different types of forward mode,
one translated further into the binding cavity with respect to
the other and occupying only the inner pockets. These
complexes were prepared by soaking the native crystals with
concentrated solutions of the appropriate ligand for a long
time. In another structural study on 3,30-T2 (Wojtczak et al.,
1992), where the complex crystals were obtained by co-
crystallization, the ligand binds in the translated forward
mode only, about 3 AÊ deeper into the channel. It is thus seen
that for the same ligand, the binding can be different
depending on how the complex was prepared. Two sets of
forward binding were also observed in the TTR±30,50-
dibromo-20,4,40,6-tetrahydroxyaurone complex (Ciszak et al.,
1992), where the phenolic Br atoms of the ligand bind in the
outer pockets exactly where the Br2 and Br6 of PBP bind, as
well as in the innermost pockets occupied by the ordered
water molecules in PBP. The translated forward binding
deeper into the binding channel was possible for these two
compounds as there is only one iodine substituent on the
phenolic ring for the ®rst compound; for the second
compound, the distance between two Br atoms on the
phenolic ring is shorter than that between two I atoms.
Thus, there are a number of ways in which TTR can
accommodate different ligands. The overall preferences of
binding are, however, for the outer pockets, with the inner
proximal pockets having the least probability of occupancy.
For the reverse binding of the thyroid hormones, when the
amino-acid side chain of the hormone is at the TTR centre, the
outer pockets are a distance of 14 AÊ from the centre.
However, for ligands in forward binding, with no halogens at
the 30,50 position, the outer pockets can be as close as 12 AÊ
from the centre. For PBP, this distance is also 12 AÊ , in spite of
being in the reverse mode, as in this case there is no amino-
acid side chain to be accommodated at the centre. Compared
with this, TBP has its outer pockets at 13 AÊ from the centre.
Most certainly the missing interactions of the Br3 and Br5
cause the TBP molecule to bind slightly away from the centre.
In the translated forward binding mode, the OH groups of
the compounds are within the hydrogen-bonding distance
from the O atoms of the four Ser117 residues at the centre of
the tetramer. Similar hydrogen bonds were found in the
structure of TTR±4,40-(OH)2-3,30,5,50-tetrachlorobiphenyl
complex (Lans et al., 1993), where it has been argued that this
hydrogen-bond formation may be an important requirement
for strong binding of OHSs to TTR, as the parent compound
without this hydroxyl group did not bind TTR (Brouwer et al.,
1990). The current study on the bromophenol complexes,
however, has shown that strong binding can take place even in
the absence of such a hydrogen-bond interaction of the OH
group of the ligand with the Ser117 residues. This agrees with
the observation that TTR binds with non-hydroxylated
compounds (Chauhan et al., 1998; Rickenbacher et al., 1986),
though the binding is weak and may imply that a much larger
number of OHSs present in the environment have the
potential to compete with thyroxine and hence adversely
affect the thyroid hormone system in animal and human.
In summary, some interesting new features have been
observed in the binding of PBP and TBP to human trans-
thyretin. The outer pockets in the TTR-binding channel seem
to be the most favoured sites for these single-ring organo-
halogen compounds, as observed in some other complexes.
The binding in the outer pockets gives the ligands greater
freedom to make stable binding interaction, while the inner
sites may be more restrictive. The symmetric disposition of the
bromines about the OÐBr4 axis in PBP and TBP molecules
has allowed the symmetry-related bromines to be accom-
modated in the TTR channel in a way that these atoms can
conform to the inherent twofold symmetry of the binding
channel and participate in energetically equivalent interac-
tions. Forward binding has not been observed at all for these
two bromophenol complexes, because the reversed binding
provided the hydroxyl group with a more polar environment.
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